HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes.


Journal

Endocrine-related cancer
ISSN: 1479-6821
Titre abrégé: Endocr Relat Cancer
Pays: England
ID NLM: 9436481

Informations de publication

Date de publication:
08 2020
Historique:
received: 21 02 2020
accepted: 25 02 2020
pubmed: 28 2 2020
medline: 31 8 2021
entrez: 28 2 2020
Statut: ppublish

Résumé

The Genetic Counseling Working Group from the 16th International Workshop on Multiple Endocrine Neoplasia (MEN 2019) convened to discuss contemporary challenges and opportunities in the area of genetic counseling for individuals and families affected by hereditary endocrine neoplasia syndromes. As healthcare professionals with multidisciplinary training in human genetics, risk assessment, patient education, psychosocial counseling, and research methodology, genetic counselors bring a unique perspective to working toward addressing these challenges and identifying their subsequent opportunities. This Working Group focused on the following broad areas: (1) genetic counseling resources for endocrine neoplasias, (2) candidate gene discovery, (3) implications of increasingly sensitive and expansive genetic testing technologies for both the germline and the tumors, and (4) situating clinical diagnoses for hereditary endocrine neoplasia syndromes in the context of present-day knowledge.

Identifiants

pubmed: 32106089
doi: 10.1530/ERC-19-0454
pii: ERC-19-0454
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

T65-T75

Auteurs

Pamela Brock (P)

Divison of Human Genetics, Department of Internal Medicine and the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

Jennifer L Geurts (JL)

Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Paulien Van Galen (P)

Hereditary Cancer Clinic and Hereditary Endocrine Clinic, Alberta Children's Hospital, Calgary, Alberta, USA.

Erica Blouch (E)

Center for Cancer Risk Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA.

James Welch (J)

Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland, USA.

Amy Kunz (A)

Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA.

Lauren Desrosiers (L)

Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

Jennifer Gauerke (J)

Center for Individualized Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Samuel Hyde (S)

Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH